TKNO Stock Analysis: Buy, Sell, or Hold?

TKNO - Alpha Teknova, Inc. Common Stock

IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
$5.30
0.30 (6.00%) ▲
5d: +9.28%
30d: -8.46%
90d: +55.88%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 05, 2026 TODAY

Get Alerted When TKNO Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: TKNO shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: TKNO is currently trading at $5.30, which is considered fair relative to its 30-day fair value range of $5.08 to $5.60.

Technical Outlook: Technically, TKNO is in a strong uptrend. Immediate support is located at $4.73, while resistance sits at $5.53. The stock is showing strong short-term momentum, up 6.0% recently.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.00 (+80.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $5.08 - $5.60
Company Quality Score 56/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 80.0%

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+6.0%)
  • BULLISH: Trading 80.0% below Wall St target ($9.00)

Trading Range Analysis

30-Day Trading Range $5.08 - $5.60
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $4.73
Resistance Level $5.53
Current Trend Strong Uptrend
Technical data as of Aug 3, 2026

Fundamental Context

Forward P/E (Next Year Est.) -20.41
Wall Street Target $9.00 (+80.0%)
Revenue Growth (YoY) 13.1%
Profit Margin -41.1%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 04, 2026 12:05 AM ET
Data refreshes hourly during market hours. Next update: 1:05 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Stephen Gunstream BUY 26000 shares 2026-03-06

Unlock Insider Activity

See real-time buying/selling by company executives for TKNO.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences I…
STRONG BUY
25 analysts
$211 60 BUY
ZTS
Zoetis Inc
BUY
20 analysts
$112 52 HOLD
UTHR
United Therapeutics Corp…
STRONG BUY
15 analysts
$663 48 HOLD
LNTH
Lantheus Holdings Inc
STRONG BUY
13 analysts
$113 45 HOLD
AVDL
Avadel Pharmaceuticals P…
STRONG BUY
8 analysts
$21 62 BUY

More Analysis for TKNO

TKNO Technical Chart TKNO Price Prediction TKNO Earnings Date TKNO Investment Advisor TKNO Fair Price Analyzer TKNO Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals